7.78
price up icon0.91%   0.06
 
loading
Chromadex Corp stock is traded at $7.78, with a volume of 81,073. It is up +0.91% in the last 24 hours and up +32.71% over the past month. ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
See More
Previous Close:
$7.72
Open:
$7.76
24h Volume:
81,073
Relative Volume:
0.11
Market Cap:
$586.18M
Revenue:
$83.57M
Net Income/Loss:
$-4.94M
P/E Ratio:
-111.14
EPS:
-0.07
Net Cash Flow:
$6.97M
1W Performance:
+1.17%
1M Performance:
+32.71%
6M Performance:
+119.44%
1Y Performance:
+280.00%
1-Day Range:
Value
$7.67
$7.84
1-Week Range:
Value
$7.3248
$8.19
52-Week Range:
Value
$2.0201
$9.18

Chromadex Corp Stock (CDXC) Company Profile

Name
Name
Chromadex Corp
Name
Phone
310-388-6706
Name
Address
10900 WILSHIRE BLVD, LOS ANGELES
Name
Employee
106
Name
Twitter
@Chromadex
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
CDXC's Discussions on Twitter

Compare CDXC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Packaged Foods icon
CDXC
Chromadex Corp
7.701 586.18M 83.57M -4.94M 6.97M -0.07
Packaged Foods icon
KHC
Kraft Heinz Co
30.39 36.98B 25.85B 2.74B 3.02B 2.26
Packaged Foods icon
GIS
General Mills Inc
59.63 33.00B 19.90B 2.60B 2.80B 4.60
Packaged Foods icon
K
Kellanova
82.26 28.11B 12.75B 1.34B 1.13B 3.87
Packaged Foods icon
MKC
Mccormick Co Inc
80.42 21.49B 6.68B 792.60M 774.40M 2.94
Packaged Foods icon
HRL
Hormel Foods Corp
29.53 16.31B 11.92B 805.04M 1.01B 1.46

Chromadex Corp Stock (CDXC) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-16-22 Downgrade Oppenheimer Outperform → Perform
Aug-11-22 Downgrade B. Riley Securities Buy → Neutral
Mar-08-22 Initiated ROTH Capital Buy
Oct-16-19 Initiated Oppenheimer Outperform
Feb-14-19 Initiated B. Riley FBR Buy
Nov-27-17 Resumed H.C. Wainwright Buy
Sep-25-17 Initiated Ladenburg Thalmann Buy
Jan-03-17 Initiated Rodman & Renshaw Buy
View All

Chromadex Corp Stock (CDXC) Latest News

pulisher
Mar 13, 2025

Q1 Earnings Forecast for ChromaDex Issued By HC Wainwright - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - BioSpace

Mar 13, 2025
pulisher
Mar 13, 2025

ChromaDex to rebrand as Niagen Bioscience and change ticker - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Major Rebrand: ChromaDex Evolves to Niagen Bioscience, Sharpens Focus on Aging Science - StockTitan

Mar 13, 2025
pulisher
Mar 11, 2025

ChromaDex to Present at the 37th Annual Roth Conference - Bluefield Daily Telegraph

Mar 11, 2025
pulisher
Mar 11, 2025

Healthy Aging Leader ChromaDex Takes Center Stage at ROTH Conference Longevity Panel - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

ChromaDex (NASDAQ:CDXC) Given New $11.00 Price Target at HC Wainwright - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

ChromaDex stock price target raised to $11 by H.C. Wainwright - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Chromadex corp. SVP buys $2,145 worth of common stock - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

ChromaDex Co. (NASDAQ:CDXC) Shares Bought by Rhumbline Advisers - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Truist Financial Corp Makes New $54,000 Investment in ChromaDex Co. (NASDAQ:CDXC) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

ChromaDex (NASDAQ:CDXC) Stock Price Expected to Rise, LADENBURG THALM/SH SH Analyst Says - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

FY2025 EPS Estimates for ChromaDex Boosted by Roth Capital - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Earnings call transcript: Chromadex’s Q4 2024 earnings beat forecasts, stock rises - Investing.com Australia

Mar 06, 2025
pulisher
Mar 06, 2025

ChromaDex Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance

Mar 06, 2025
pulisher
Mar 05, 2025

ChromaDex stock soars to 52-week high, touches $7.98 By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

ChromaDex Reports Record Revenues Amid Challenges - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Tru Niagen’s ChromaDex reports profit, nearly $100 million in yearly sales - SupplySide Supplement Journal

Mar 05, 2025
pulisher
Mar 05, 2025

ChromaDex stock soars to 52-week high, touches $7.98 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

ChromaDex Corporation (NASDAQ:CDXC) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 05, 2025
pulisher
Mar 05, 2025

ChromaDex: Q4 Earnings Snapshot - Midland Daily News

Mar 05, 2025
pulisher
Mar 05, 2025

ChromaDex Corp (CDXC) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advances - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

ChromaDex shares rise as Q4 results top estimates - Investing.com India

Mar 05, 2025
pulisher
Mar 04, 2025

ChromaDex Reports Strong 2024 Financial Performance - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings call transcript: Chromadex’s Q4 2024 earnings beat forecasts, stock rises By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Chromadex Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

ChromaDex (CDXC) Q4 Earnings and Revenues Surpass Estimates - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results - BioSpace

Mar 04, 2025
pulisher
Mar 04, 2025

Chromadex Corp earnings beat by $0.07, revenue topped estimates - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

CHROMADEX Earnings Results: $CDXC Reports Quarterly Earnings - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

ChromaDex shares rise as Q4 results top estimates By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results -March 04, 2025 at 04:56 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Chromadex Reports Strong Q4 2024 Financial Growth - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

ChromaDex: Q4 Earnings Snapshot -March 04, 2025 at 04:17 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

ChromaDex sees FY25 revenue growth roughly 18% - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

ChromaDex sees FY25 revenue up 18% - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

What To Expect From ChromaDex Corp (CDXC) Q4 2024 Earnings - GuruFocus.com

Mar 03, 2025
pulisher
Mar 02, 2025

CHROMADEX Earnings Preview: Recent $CDXC Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 02, 2025
pulisher
Mar 02, 2025

ChromaDex (CDXC) Expected to Announce Earnings on Tuesday - Defense World

Mar 02, 2025
pulisher
Feb 28, 2025

ChromaDex (NASDAQ:CDXC) Rating Increased to Strong-Buy at StockNews.com - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Dartmouth Wants Fed. Circ. To Ax Fees After Vitamin IP Loss - Law360

Feb 28, 2025
pulisher
Feb 28, 2025

Chromadex Corp expected to post earnings of 2 cents a shareEarnings Preview - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

ChromaDex analysis of NR products yields ‘disappointing’ results - NutraIngredients-usa.com

Feb 28, 2025
pulisher
Feb 27, 2025

Investor Network: ChromaDex Corporation to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

ChromaDex Corporation to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Chromadex Corp Stock (CDXC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Chromadex Corp Stock (CDXC) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Jaksch Frank L Jr
Director
Dec 13 '24
Option Exercise
3.66
50,001
183,004
281,340
Jaksch Frank L Jr
Director
Dec 13 '24
Sale
6.19
37,161
229,956
244,179
$66.44
price up icon 0.50%
packaged_foods CPB
$38.38
price up icon 0.08%
packaged_foods SJM
$111.86
price down icon 0.14%
packaged_foods PPC
$50.65
price up icon 2.46%
packaged_foods CAG
$25.80
price down icon 0.46%
packaged_foods HRL
$29.35
price down icon 0.61%
Cap:     |  Volume (24h):